(Q35177548)

6 August 2017

1 reference

title

Immunodeficiency and cancer: prospects for correction (English)

1 reference

6 August 2017

John W Hadden

1

1 reference

6 August 2017

publication date

1 August 2003

1 reference

International Immunopharmacology

6 August 2017

published in

1 reference

6 August 2017

volume

3

1 reference

6 August 2017

issue

8

1 reference

6 August 2017

page(s)

1061-1071

1 reference

The influence of an aging immune system on cancer incidence and progression

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

Tumor antigens recognized by T lymphocytes

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

Genes Coding for Tumor Antigens Recognized by Cytolytic T Lymphocytes

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

Patterns of Human Tumor-Infiltrating Lymphocytes in 120 Human Cancers

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

Signaling defects in T lymphocytes of patients with malignancy

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

An approach to the serodiagnosis of human lung cancer.Cell culture lines reactive as antigens with tumor patients' sera

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

New approaches for the development and application of monoclonal antibodies for the diagnosis and therapy of human cancer

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

Serological identification of human tumor antigens

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

Role of SEREX-defined immunogenic wild-type cellular molecules in the development of tumor-specific immunity

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

Bronchogenic carcinoma: immunologic aspects

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

Suppressor mechanisms in tumor immunity

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

Immunobiology and immunotherapy of head and neck cancer

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

Infections in cancer patients with suppressed cellular immunity

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

The treatment of zinc deficiency is an immunotherapy

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

Nutritional status and general immune competence in patients with head and neck cancer

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

Inhibitory factors derived from human tumors: isolation of factors which suppress macrophage mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

Nonspecific immunosuppression by cultured lymphocyte supernates of cancer patients

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

Immunosuppressive plasma factors in malignant disease.

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

Depressed immune surveillance against cancer: role of deficient T cell: extracellular matrix interactions

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta).

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

Transforming growth factor-beta. Multiple actions and potential clinical applications

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

Distribution of retroviral p15E-related proteins in neoplastic and non-neoplastic human tissues, and their role in the regulation of the immune response

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

Prostaglandin E2 of the upper aerodigestive tract

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

Prostaglandins and host defense in cancer

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

Tumor-derived growth factors that support proliferation and differentiation of normal and leukemic hemopoietic cells.

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

Myeloid progenitor cells mediate immune suppression in patients with head and neck cancers

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

Clinical Applications of Serum Tumor Markers

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

Tumour markers in oncology: past, present and future

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

Clinical tumour markers in lung cancer

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

Immunologic factors in melanoma

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

Effects of UV radiation on tumor immunity

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

Immune complexes, serum proteins, cell-mediated immunity, and immune regulation in patients with squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

Cytokines and immune response in the tumor microenvironment

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

Need for immunologic stimulators during immunosuppression produced by major cancer surgery

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

Characterization of the anti-tumor immune response in human cancers and strategies for immunotherapy

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

T‐Cell Immunotherapy of Tumors by Adoptive Transfer of Cytotoxic T Lymphocytes and by Vaccination with Minimal Essential Epitopes

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

Biological implications of HLA-DR expression in tumours

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

MHC class II restricted tumor antigens and the role of CD4 T cells in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

Human tumor antigens for cancer vaccine development

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

Heat shock proteins: the 'Swiss Army Knife' vaccines against cancers and infectious agents

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

Molecular chaperones in the etiology and therapy of cancer

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

Cancer gene therapy: fringe or cutting edge?

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

1 reference

7 January 2021

Rational interleukin 2 therapy for HIV positive individuals: daily low doses enhance immune function without toxicity

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

A potential role for interleukin-7 in T-cell homeostasis

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

Interleukin-7 restores immunity in athymic T-cell-depleted hosts

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

1 reference

7 January 2021

Adjuvant Therapy of Colorectal Cancer

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

Immunotherapy with natural interleukins and/or thymosin alpha 1 potently augments T-lymphocyte responses of hydrocortisone-treated aged mice

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

Zinc induces thymulin secretion from human thymic epithelial cells in vitro and augments splenocyte and thymocyte responses in vivo

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

Age, thymopoiesis, and CD4 T-lymphocyte regeneration after intensive chemotherapy

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

Evaluation of thymopoiesis using T cell receptor excision circles (TRECs): differential correlation between adult and pediatric TRECs and naïve phenotypes

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016/S1567-5769(03)50060-2

7 January 2021

10.1016/S1567-5769(03)00060-2

Identifiers

DOI

1 reference

6 August 2017

1 reference